Vivacell Biotechnology España, S.L.
Contacto
Dra. M.Luz Bellido Cabello de Alba. Managing Director
Dirección: Parque Científico Tecnológico de Córdoba, Rabanales 21 C/ Astrónoma Cecilia Payne, ID8.1, Edificio Centauro, Primera Planta
Ciudad: 14014 Córdoba
Provincia: Córdoba
Tel.: 34 957290666
m.bellido@vivacellspain.com
http://www.vivacellspain.com
Productos/Servicios, Áreas de interés para futuras colaboraciones
VivaCell is committed to discover and to develop new natural-derived drugs, specially phytocannabinoids, for the treatment of chronic inflammatory and neurodegenerative diseases. VivaCell has developed a secuential platform of primary and secondary screenings that are able to analyse more than 20 key molecular targets in inflammation and cancer pathways. We are expert in screening of hit compounds, identification of mechanism of action and assessment of the efficacy of molecules and phytoextracts for pharmaceutical, nutraceutical and cosmetic uses.
Currently we have three R&D programs ongoing:
•Neuroinflammation
•Fibrosis
•Cannabis phytoextracts
The specific aims of our R&D programs are:
•Development of VCE-003 and VCE-004 Series in neurodegenerative diseases.
•Development of VCE-004 Series in Scleroderma.
•Discovery and development of new VCE-003 derivatives.
•Discovery and development of new Triterpenoids for therapeutic use.
•Development of CDE-001 for improvement of skin conditions.
Permalink  

 
Vivacell Biotechnology España, S.L.
Desarrollado por Web4Bio